Publication dates

Rheumatoid Arthritis Industry, January 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, disease testing, biosimilar, hip replacement, total hip replacement, drug, drug delivery, plc, injectable drug delivery, microbiology, pain management therapeutics, sports medicine.


 
1-10 of about 100 reports for Rheumatoid Arthritis

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... To prevent bone and joint diseases and conditions, such as osteoporosis, osteoarthritis, and rheumatoid arthritis. Its projects include capthymone, capsitonin, tnf regularors bn006 and bone cell regulators bn ...

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Of rheumatoid arthritis, glaucoma and psoriasis. Its cf 102, is an oral drug used to treat liver cancer and cf 602, is an allosteric modulator used in the treatment of inflammatory diseases. The company conducts ...

MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Diagnostic and research applications. It offers therapeutic treatment for various diseases including cancer, rheumatoid arthritis and alzheimer's disease. The company has developed various patented antibody ...

Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Of autoimmune and inflammatory diseases. Its products under clinical development include tnf-kinoid and ifna-kinoid. Neovacs's products are used in the treatment of rheumatoid arthritis, crohn's disease, cancer ...

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Such as fatigue and appetite loss, anemia, colorectal cancer, liver cancer, rheumatoid arthritis and hepatitis c, among others. The company has collaboration with multinational pharmaceutical or biotech companies ...

Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Phospholipids and antioxidants purified from the precursor neptune krill oil. It serves patients with atherosclerosis, diabetes, rheumatoid arthritis, and gastroenterology disorders. The company operates ...

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Sclerosis and rheumatoid arthritis; rhb-105, an antibiotic and proton pump inhibitor proprietary drug combination in phase iii clinical trials for the treatment of helicobacter pylori (h. Pylori) infection ...

Conpharm AB (CONP B) - Financial and Strategic SWOT Analysis Review

Conpharm AB (CONP B) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... On substances extracted from the podophyllum plant worldwide. Its sectors include podophyllum emodi, wartec and condyloma, and reumacon and rheumatoid arthritis. Conpharm's product wartec is used ...

Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Thrombocytopenic purpura, rheumatoid arthritis, systemic lupus erythematosus, asthma and b cell cancers. The company has partnerships with biogen idec for the development of prt2607. It also has collaborations ...

Galapagos NV (GLPGA) - Financial and Strategic SWOT Analysis Review

Galapagos NV (GLPGA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Glpg0778/555 is used for the treatment of immuno and inflammatory diseases. Galapagos's glpg0634 is an orally-available, selective inhibitor of jak1 used for the treatment of rheumatoid arthritis ...

About 1 300 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Astellas Annual Report 2013

  • January 2013
    142 pages
  • Drug  

  • Japan  

    World  

    Asia  

View report >

2 Companies for Rheumatoid Arthritis

Read our Company Profiles

Johnson and Johnson

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.